London stocks lagged Tuesday as FTSE 100 missed surge in other corners
The FTSE 100 edged lower Thursday, though the main index drop didn’t tell the whole story. A big pharmaceutical stock weighed on the benchmark, but banks, miners, tech names and mid-cap shares all moved up in the background. FTSE 100 slipped 0.2% to 10,472.5. Gains in banks, up 2.2%, and miners, both industrial and precious-metal names, up over 4%, couldn’t make up for AstraZeneca’s trial news. The FTSE 250 added 1.0%, breaking a three-day losing streak and suggesting investors aren’t just pulling out of UK names.